THE REFS BET
The refs bet. We keep score.

SRPT — Sarepta Therapeutics, Inc. - Common Stock (SRPT)

Every disclosed congressional transaction in this security, both parties, every chamber. Each row links to the filing it came from.

These are legally required disclosures, not allegations — timing can be coincidence.

Transactions 17 
Members involved 3 
Buys 11 
Sells 6 

Who trades it, and which way

By party

Democrats: 17 (100%)

Democrats 17 Republicans 0

By direction

Purchases: 11 (65%)Sales: 6 (35%)

Purchases 11 Sales 6

Inside its sector Pharmaceuticals & Biotech

Congressional transactions per security in this sector — the page you are on is highlighted.

JNJ 225
PFE 154
MRK 142
LLY 141
ABBV 134
ABT 117
AMGN 103
SRPT 17

Plus 1,054 transactions across the sector's other securities.

Follow the federal money

Why a company's stock can be sensitive to what Congress does: many of them are also paid by the government. Sarepta Therapeutics, Inc.'s federal contracts, grants and loans are public record.

Look up Sarepta Therapeutics, Inc. on USASpending →

We link to the source rather than repeat a dollar figure here. Federal awards are recorded under many recipient names — a parent company and its subsidiaries — so an accurate company-wide total has to be read at USASpending itself, where the recipient hierarchy is resolved. Present this beside the trading record and draw your own conclusions.

Instant Replay

17 trades · 87 committee-days

Adjusted closing price with every disclosed transaction (▲ buy / ▼ sell) and the committee activity in this security's sector within 30 days. A highlighted event line means a member who traded this security sat on that committee. Proximity is shown, not causation.

Hover the chart for prices, trades, and committee activity.

Transactions

DateMemberActionAmount (as filed)OwnerFiling
2025-04-14 Gilbert Ray Cisneros, Jr. D-CA sell $1,001 – $15,000 self
2023-07-14 Josh Gottheimer D-NJ buy $1,001 – $15,000 joint
2023-06-13 Josh Gottheimer D-NJ sell $1,001 – $15,000 joint
2023-04-10 Daniel S. Goldman D-NY sell $15,001 – $50,000 self
2023-03-06 Daniel S. Goldman D-NY buy $15,001 – $50,000 self
2023-03-06 Josh Gottheimer D-NJ buy $1,001 – $15,000 joint
2023-01-31 Daniel S. Goldman D-NY sell $1,001 – $15,000 self
2020-11-06 Josh Gottheimer D-NJ sell $1,001 – $15,000 joint
2020-09-14 Gilbert Ray Cisneros, Jr. D-CA buy $1,001 – $15,000 self
2020-06-10 Gilbert Ray Cisneros, Jr. D-CA sell $1,001 – $15,000 self
2019-12-13 Josh Gottheimer D-NJ buy $1,001 – $15,000 joint
2019-10-11 Gilbert Ray Cisneros, Jr. D-CA buy $1,001 – $15,000 self
2019-10-10 Gilbert Ray Cisneros, Jr. D-CA buy $1,001 – $15,000 self
2019-04-09 Gilbert Ray Cisneros, Jr. D-CA buy $1,001 – $15,000 self
2019-03-11 Gilbert Ray Cisneros, Jr. D-CA buy $1,001 – $15,000 self
2019-02-27 Gilbert Ray Cisneros, Jr. D-CA buy $1,001 – $15,000 self
2019-02-26 Gilbert Ray Cisneros, Jr. D-CA buy $1,001 – $15,000 self

Prices are market data (split- and dividend-adjusted closes), used only for context — every disclosure fact on this page comes from the filings linked in the table above. See Methodology.